Coherus Oncology Inc (CHRS)

Operating Cash Flow

-$243.92M

TTM · Period ending: · USD

CHRS logo

CHRS Operating Cash Flow

Latest reported-$243.92M
CHRS Operating Cash Flow (-$18.25M → -$243.92M)
High-resolution chart · PNG

CHRS operating cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Operating Cash Flow — Annual fiscal periods (USD)
Period endingOperating Cash Flow (USD)
-138,513,000
-20,440,000
-174,884,000
-241,124,000
-37,432,000
154,145,000
28,355,000
-159,266,000
-200,286,000
-252,545,000
-107,990,000
-23,927,000
15,423,000
-18,251,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.